1
|
Ataş K, Kaya Mutlu E. Is sexual function impaired in patients with primary headaches? A systematic review of observational studies. Sex Med Rev 2024:qeae064. [PMID: 39385631 DOI: 10.1093/sxmrev/qeae064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2024] [Revised: 08/06/2024] [Accepted: 08/09/2024] [Indexed: 10/12/2024]
Abstract
INTRODUCTION Primary headaches, particularly migraine and tension-type headaches, as chronic and painful conditions, have a significant impact on individuals' health and overall quality of life, including aspects such as sexual health parameters. OBJECTIVES The aim of this study was to review observational studies and to summarize the presence of sexual dysfunction in patients with primary headache and to discern whether it is more common in patients with primary headache than in healthy control subjects. METHODS Observational studies published between January 1, 2000, and May 21, 2023 were searched in Medline (PubMed), Web of Science, Scopus, and EBSCO. This review included 23 observational studies that evaluated sexual dysfunction with or without comparison with healthy control subjects. RESULTS As a result, the mean Female Sexual Function Index score, a score of <26.55 indicating sexual dysfunction, ranged from 19.25 ± 8.18 to 27.5 ± 7.5 in patients with primary headache. The prevalence of sexual dysfunction and erectile dysfunction was found to be between 10.7% and 93.75% in female patients and between 54.83% and 80% in male patients. Both migraineurs and tension-type headache sufferers had statistically significantly lower sexual function scores in females and lower erectile function scores in males compared with healthy control subjects. CONCLUSION Sexual function is significantly affected in patients with primary headache, which is a chronic painful disorder. Therefore, it is very important to ask these patients about their sexual health and, if necessary, to seek support from a sexual health professional. Additionally, future studies may prioritize tension-type headaches and male patients due to the limited amount of research available on these subjects.
Collapse
Affiliation(s)
- Kübra Ataş
- Department of Physiotherapy and Rehabilitation, Munzur University, Faculty of Health Science, Aktuluk Kampüsü, 62000 Merkez, Tunceli, Turkey
| | - Ebru Kaya Mutlu
- Department of Physiotherapy and Rehabilitation, Faculty of Health Science, Bandirma Onyedi Eylul University, Kurtuluş Cad. Askerlik Şubesi Yanı No: 98 10200 Bandırma, Balikesir, Turkey
| |
Collapse
|
2
|
Bertão M, Martins B, Costa A. Female sexual dysfunction and distress in premenopausal women with migraine followed in a tertiary headache center: A pilot study. Clin Neurol Neurosurg 2024; 245:108476. [PMID: 39151222 DOI: 10.1016/j.clineuro.2024.108476] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2024] [Revised: 07/27/2024] [Accepted: 07/30/2024] [Indexed: 08/19/2024]
Abstract
BACKGROUND Female sexual dysfunction (FSD) is an underdiagnosed and undertreated problem. Few studies have addressed sexual distress in migraine. We aimed to perform a pilot study to determine if there is an association between migraine and sexual dysfunction/distress in premenopausal women and to identify their respective risk factors. METHODS Retrospective, cross-sectional pilot study, including 71 premenopausal female patients with migraine, from the headache outpatient clinic of a tertiary hospital, and 34 age-matched-controls. Female Sexual Function Index-6 (FSFI-6), Female Sexual Distress Scale-Revised (FSDS-R), Migraine Disability Assessment (MIDAS) Scale, Brief Pain Inventory (BPI), Hospital Anxiety and Depression Scale (HADS) and Sleep Health Scale (RU-SATED) were applied. RESULTS Of the 71 patients [40.0 (IQR = 11.00) years], only 12.7 % (n = 9) were not under migraine prophylactic treatment, and most (n = 33, 62.3 %) reported severe disability (MIDAS-IV). FSD and sexual distress were present in 50.7 % (36) patients with migraine [vs 20.6 % (7) controls]. Migraine patients showed lower FSFI-6 scores [19.0 (9.0) vs 24.0 (6.0), p = 0.005], with significantly lower levels of desire (p = 0.011), lubrication (p = 0.002), and satisfaction (p = 0.013), higher sexual distress [11.2 (25.6) vs 3.2 (9.6), p = 0.001], anxiety (p < 0.001), and depression (p < 0.001) levels, and lower sleep health scores (p = 0.005). Old age of onset, being under preventive medication, anxiety/depression, and dysfunctional sleep, were significantly associated with sexual distress. Certain domains of sexual function were associated with sociodemographic and migraine characteristics, anxiety, depression, and sleep health. CONCLUSIONS This pilot study highlights the possible association between migraine and elevated sexual dysfunction/distress levels among premenopausal women. It underscores the importance of sexual health assessments in these individuals, particularly those with higher levels of anxiety, depression, or poor sleep quality. It is important to exercise caution when interpreting results, as they may not be applicable to a wider context. This research paves the way for a larger study that will include a broader population of women from the community and encompass patients followed in different levels of health care.
Collapse
Affiliation(s)
- Matilde Bertão
- Faculty of Medicine, University of Porto, Porto, Portugal.
| | - Bárbara Martins
- Clinical Neuroscience and Mental Health Department, Faculty of Medicine, University of Porto, Porto, Portugal; Neurology Department, Unidade Local de Saúde de São João, E.P.E., Porto, Portugal
| | - Andreia Costa
- Clinical Neuroscience and Mental Health Department, Faculty of Medicine, University of Porto, Porto, Portugal; Neurology Department, Unidade Local de Saúde de São João, E.P.E., Porto, Portugal
| |
Collapse
|
3
|
Kamel RM, Dantata BA, Halilu H, Ahmed HM, Muzaffar KH, Maria NT, Alsadeq HR. Sexual dysfunction in migraine-affected women: A prospective cross-sectional controlled study. Eur J Obstet Gynecol Reprod Biol X 2024; 23:100319. [PMID: 39035702 PMCID: PMC11260330 DOI: 10.1016/j.eurox.2024.100319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2024] [Revised: 06/04/2024] [Accepted: 06/09/2024] [Indexed: 07/23/2024] Open
Abstract
Introduction Female sexual dysfunction (FSD) is a common health problem that is inadequately investigated in Arabic countries, especially Saudi Arabia. Aim To assess the prevalence and trace predictors of FSD in Saudi women who suffered from migraine headaches comparable to healthy women. Patients and methods A prospective cross-sectional, controlled study involved 400 Saudi women complaining of migraine (Case Group) and another 400 healthy-looking Saudi women (Control Group) during three months; from January 1st, to March 31st 2023, in Jeddah city, Saudi Arabia. Data was collected by using a pre-structured Female Sexual Function Index (FSFI) questionnaire, Female Sexual Distress Scale (FSDS), Migraine Screen Questionnaire (MS-Q), with an evaluation of the severity of pain by Visual Analogue Scale (VAS), and its impact on daily activity by using both; Headache Impact Test (HIT-6) and Migraine Disability Assessment (MIDAS) Questionnaire. Results A total of 800 Saudi women were recruited. Their ages ranged from 18 to 45 years old. Women with abnormally low FSFI scores were 375 (93.75 %) out of 400 with migraine and 85 (21.25 %) out of 400 without migraine. The lowest FSFI scores were mainly for desire (2.75 ± 1.05) and arousal domains (3.0 ± 1.12) followed by sexual satisfaction (3.25 ± 1.30) and orgasmic domains (3.5 ± 1.15). The foremost predictive factor behind low FSFI scores and associated FSD in our study was migraine (P < 0.00001). Additional predictors of statistical significance were low educational level (P < 0.01), urban residency (P < 0.02), high parity (P < 0.02), chronic illness such as diabetes (P < 0.01), and bad habits such as smoking (P < 0.03). Conclusion A significant correlation exists between migraine and female sexual dysfunction (FSD). Desire and arousal dysfunctions were the most significantly affected domains followed by satisfaction and orgasmic problems.
Collapse
Affiliation(s)
- Remah M. Kamel
- Professor of Obstetrics & Gynaecology, General Medicine Practice Program, Batterjee Medical College (BMC), Jeddah 21442, Saudi Arabia
| | - Baraatu A. Dantata
- Medical Interns from the General Medicine Practice Program, Batterjee Medical College (BMC), Jeddah 21442, Saudi Arabia
| | - Hadiza Halilu
- Medical Interns from the General Medicine Practice Program, Batterjee Medical College (BMC), Jeddah 21442, Saudi Arabia
| | - Hafsah M. Ahmed
- Medical Interns from the General Medicine Practice Program, Batterjee Medical College (BMC), Jeddah 21442, Saudi Arabia
| | - Khadijah H. Muzaffar
- Medical Interns from the General Medicine Practice Program, Batterjee Medical College (BMC), Jeddah 21442, Saudi Arabia
| | - Nishat T. Maria
- Medical Interns from the General Medicine Practice Program, Batterjee Medical College (BMC), Jeddah 21442, Saudi Arabia
| | - Hussain R. Alsadeq
- Medical Interns from the General Medicine Practice Program, Batterjee Medical College (BMC), Jeddah 21442, Saudi Arabia
| |
Collapse
|
4
|
Ferrández Infante A, Novella Arribas B, Khan KS, Zamora J, Jurado López AR, Fragoso Pasero M, Suárez Fernández C. Obesity and female sexual dysfunctions: A systematic review of prevalence with meta-analysis. Semergen 2023; 49:102022. [PMID: 37331210 DOI: 10.1016/j.semerg.2023.102022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2023] [Revised: 05/22/2023] [Accepted: 05/24/2023] [Indexed: 06/20/2023]
Abstract
Obesity represents a major global health challenge. Female sexual dysfunctions have a negative impact on quality of life and overall health balance. A higher rate of female sexual dysfunctions in obese women has been suggested. This systematic review summarized the literature on female sexual dysfunction prevalence in obese women. The review was registered (Open Science Framework OSF.IO/7CG95) and a literature search without language restrictions was conducted in PubMed, Embase and Web of Science, from January 1990 to December 2021. Cross-sectional and intervention studies were included, the latter if they provided female sexual dysfunction rate data in obese women prior to the intervention. For inclusion, studies should have used the female sexual function index or its simplified version. Study quality was assessed to evaluate if female sexual function index was properly applied using six items. Rates of female sexual dysfunctions examining for differences between obese vs class III obese and high vs low quality subgroups were summarized. Random effects meta-analysis was performed, calculating 95% confidence intervals (CI) and examining heterogeneity with I2 statistic. Publication bias was evaluated with funnel plot. There were 15 relevant studies (1720 women participants in total with 153 obese and 1567 class III obese women). Of these, 8 (53.3%) studies complied with >4 quality items. Overall prevalence of female sexual dysfunctions was 62% (95% CI 55-68%; I2 85.5%). Among obese women the prevalence was 69% (95% CI 55-80%; I2 73.8%) vs 59% (95% CI 52-66%; I2 87.5%) among those class III obese (subgroup difference p=0.15). Among high quality studies the prevalence was 54% (95% CI 50-60%; I2 46.8%) vs 72% (95% CI 61-81%; I2 88.0%) among low quality studies (subgroup difference p=0.002). There was no funnel asymmetry. We interpreted that the rate of sexual dysfunctions is high in obese and class III obese women. Obesity should be regarded as a risk factor for female sexual dysfunctions.
Collapse
Affiliation(s)
- A Ferrández Infante
- Coordinator of the Primary Care Physicians Spanish Society (SEMERGEN) Sexology Working Group, Guadarrama Continuity Care Center, 28440 Madrid, Spain.
| | - B Novella Arribas
- Grupo de Investigación 49, Instituto de Investigación del Hospital Universitario de La Princesa, Foundation for Biomedical Research and Innovation in Primary Care of the Community of Madrid (FIIBAP), 28006 Madrid, Spain
| | - K S Khan
- Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain; Department of Preventive Medicine and Public Health, University of Granada, 18016 Granada, Spain
| | - J Zamora
- Head of the Clinical Biostatistics Unit, Hospital Ramón y Cajal, IRYCIS, 28034 Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain
| | - A R Jurado López
- Member of the Primary Care Physicians Spanish Society (SEMERGEN) Sexology Working Group, President of the European Institute of Sexology, 29602 Marbella, Spain
| | - M Fragoso Pasero
- Biostatistician, Grupo de Investigación 49, Instituto de Investigación del Hospital Universitario de La Princesa, Foundation for Biomedical Research and Innovation in Primary Care of the Community of Madrid (FIIBAP), 28006 Madrid, Spain
| | - C Suárez Fernández
- Head of the Internal Medicine Service of the Hospital Universitario de La Princesa, 28006 Madrid, Spain
| |
Collapse
|
5
|
Torres-Ferrus M, López-Veloso AC, Gonzalez-Quintanilla V, González-García N, Díaz de Teran J, Gago-Veiga A, Camiña J, Ruiz M, Mas-Sala N, Bohórquez S, Gallardo VJ, Pozo-Rosich P. The MIGREX study: Prevalence and risk factors of sexual dysfunction among migraine patients. Neurologia 2023; 38:541-549. [PMID: 37802552 DOI: 10.1016/j.nrleng.2021.02.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2020] [Accepted: 02/07/2021] [Indexed: 10/10/2023] Open
Abstract
BACKGROUND Migraine attacks have a high impact on daily activities. There is limited research on the burden of migraine on sexual functioning. OBJECTIVE To determine the prevalence of sexual dysfunction in patients with migraine and its relationship with migraine features and comorbidities. METHOD This is a cross-sectional study. We included migraine patients between 18 and 60 years-old from 8 Headache Clinics in Spain. We recorded demographic data and migraine features. Patients fulfilled a survey including comorbidities, Arizona Sexual Experiences Scale, Hospital Anxiety and Depression Scale and a questionnaire about migraine impact on sexual activity. A K-nearest neighbor supervised learning algorithm was used to identify differences between migraine patients with and without sexual dysfunction. RESULTS We included 306 patients (85.6% women, mean age 42.3±11.1 years). A 41.8% of participants had sexual dysfunction. Sexual dysfunction was associated with being female (OR [95% CI]: 2.42 [1.17-5.00]; p<0.001), being older than 46.5 years (4.04 [2.48-6.59]; p<0.001), having chronic migraine (2.31 [1.41-3.77]; p=0.001), using preventive medication (2.45 [1.35-4.45]; p=0.004), analgesic overusing (3.51 [2.03-6.07]; p<0.001), menopause (4.18 [2.43-7.17]; p<0.001) and anxiety (2.90 [1.80-4.67]; p<0.001) and depression (6.14 [3.18-11.83]; p<0.001). However, only female gender, age, menopause and depression were the statistically significant variables selected in the model to classify migraine patients with or without sexual dysfunction (Accuracy [95% CI]: 0.75 (0.62-0.85), Kappa: 0.48, p=0.005). CONCLUSIONS Sexual dysfunction is frequent in migraine patients visited in a headache clinic. However, migraine characteristics or use of preventive medication are not directly associated with sexual dysfunction. Instead, risk factors for sexual dysfunction were female gender, higher age, menopause and depression.
Collapse
Affiliation(s)
- M Torres-Ferrus
- Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
| | - A C López-Veloso
- Neurology Department, Gran Canaria Dr. Negrín University Hospital, Las Palmas de Gran Canaria, Spain
| | | | | | - J Díaz de Teran
- Neurology Department, La Paz University Hospital, Madrid, Spain
| | - A Gago-Veiga
- Neurology Department, La Princesa University Hospital, Madrid, Spain
| | - J Camiña
- Neurology Department, Rotger Clinic, Palma de Mallorca, Spain
| | - M Ruiz
- Neurology Department, San Juan Hospital, Alicante, Spain
| | - N Mas-Sala
- Neurology Department, Althaia Hospital, Red Asistencial Universitaria de Manresa, Spain
| | - S Bohórquez
- Neurology Department, Sabana University, Bogotá, Colombia
| | - V J Gallardo
- Neurology Department, Sabana University, Bogotá, Colombia
| | - P Pozo-Rosich
- Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain
| |
Collapse
|
6
|
Torres-Ferrus M, López-Veloso AC, Gonzalez-Quintanilla V, González-García N, Díaz de Teran J, Gago-Veiga A, Camiña J, Ruiz M, Mas-Sala N, Bohórquez S, Gallardo VJ, Pozo-Rosich P. The MIGREX study: Prevalence and risk factors of sexual dysfunction among migraine patients. Neurologia 2021; 38:S0213-4853(21)00036-0. [PMID: 33766414 DOI: 10.1016/j.nrl.2021.02.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2020] [Revised: 01/04/2021] [Accepted: 02/07/2021] [Indexed: 10/21/2022] Open
Abstract
BACKGROUND Migraine attacks have a high impact on daily activities. There is limited research on the burden of migraine on sexual functioning. OBJECTIVE To determine the prevalence of sexual dysfunction in patients with migraine and its relationship with migraine features and comorbidities. METHOD This is a cross-sectional study. We included migraine patients between 18 and 60 years-old from 8 Headache Clinics in Spain. We recorded demographic data and migraine features. Patients fulfilled a survey including comorbidities, Arizona Sexual Experiences Scale, Hospital Anxiety and Depression Scale and a questionnaire about migraine impact on sexual activity. A K-nearest neighbor supervised learning algorithm was used to identify differences between migraine patients with and without sexual dysfunction. RESULTS We included 306 patients (85.6% women, mean age 42.3±11.1 years). A 41.8% of participants had sexual dysfunction. Sexual dysfunction was associated with being female (OR [95% CI]: 2.42 [1.17-5.00]; p<0.001), being older than 46.5 years (4.04 [2.48-6.59]; p<0.001), having chronic migraine (2.31 [1.41-3.77]; p=0.001), using preventive medication (2.45 [1.35-4.45]; p=0.004), analgesic overusing (3.51 [2.03-6.07]; p<0.001), menopause (4.18 [2.43-7.17]; p<0.001) and anxiety (2.90 [1.80-4.67]; p<0.001) and depression (6.14 [3.18-11.83]; p<0.001). However, only female gender, age, menopause and depression were the statistically significant variables selected in the model to classify migraine patients with or without sexual dysfunction (Accuracy [95% CI]: 0.75 (0.62-0.85), Kappa: 0.48, p=0.005). CONCLUSIONS Sexual dysfunction is frequent in migraine patients visited in a headache clinic. However, migraine characteristics or use of preventive medication are not directly associated with sexual dysfunction. Instead, risk factors for sexual dysfunction were female gender, higher age, menopause and depression.
Collapse
Affiliation(s)
- M Torres-Ferrus
- Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
| | - A C López-Veloso
- Neurology Department, Gran Canaria Dr. Negrín University Hospital, Las Palmas de Gran Canaria, Spain
| | | | | | - J Díaz de Teran
- Neurology Department, La Paz University Hospital, Madrid, Spain
| | - A Gago-Veiga
- Neurology Department, La Princesa University Hospital, Madrid, Spain
| | - J Camiña
- Neurology Department, Rotger Clinic, Palma de Mallorca, Spain
| | - M Ruiz
- Neurology Department, San Juan Hospital, Alicante, Spain
| | - N Mas-Sala
- Neurology Department, Althaia Hospital, Red Asistencial Universitaria de Manresa, Spain
| | - S Bohórquez
- Neurology Department, Sabana University, Bogotá, Colombia
| | - V J Gallardo
- Neurology Department, Sabana University, Bogotá, Colombia
| | - P Pozo-Rosich
- Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain
| |
Collapse
|
7
|
Schumacher L, Wing R, Thomas JG, Pavlovic J, Digre K, Farris S, Steffen K, Sarwer D, Bond D. Does sexual functioning improve with migraine improvements and/or weight loss?-A post hoc analysis in the Women's Health and Migraine (WHAM) trial. Obes Sci Pract 2020; 6:596-604. [PMID: 33354338 PMCID: PMC7746968 DOI: 10.1002/osp4.443] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2019] [Revised: 06/12/2020] [Accepted: 06/16/2020] [Indexed: 12/02/2022] Open
Abstract
BACKGROUND Despite plausibility of migraine headaches contributing to impaired sexual function among women, data are inconsistent and point to obesity as a potential confounder. Prospective studies that assess the relative importance of migraine improvements and weight loss in relation to sexual function could help elucidate associations among migraine, obesity and female sexual dysfunction (FSD). OBJECTIVE To evaluate sexual function changes and predictors of improvement after behavioural weight loss (BWL) intervention for migraine or migraine education (ME). METHODS Women with migraine and overweight/obesity were randomized to 16 weeks of BWL (n = 54) or ME (n = 56). Participants completed a 4-week smartphone headache diary and the Female Sexual Function Index (FSFI) at pre- and post-treatment. A validated FSFI total cut-off score defined FSD. We compared changes in FSFI scores and FSD rates between conditions and evaluated migraine improvements and weight loss as predictors of sexual functioning in the full sample. RESULTS Among treatment completers (n = 85), 56 (65.9%) participants who reported sexual activity at pre- and post-treatment were analysed. Migraine improvements were similar between conditions, whereas BWL had greater weight losses compared with ME. FSD rates did not change overall (48.2% to 44.6%, p = .66) or by condition (BWL: 56.0% to 40.0% vs. ME: 41.9% to 48.4%, p = .17). Similar patterns were observed for changes in FSFI total and subscale scores. Across conditions, larger weight losses predicted greater improvements in FSFI total and arousal subscale scores, whereas larger migraine headache frequency reductions predicted greater improvements in FSFI satisfaction subscale scores. CONCLUSION Sexual functioning did not improve with either BWL or ME despite migraine headache improvements in both conditions and weight loss after BWL. However, weight loss related to improvements in physiological components of the sexual response (i.e., arousal) and overall sexual functioning, whereas reduced headache frequency related to improved sexual satisfaction. Additional research with larger samples is needed.
Collapse
Affiliation(s)
- Leah Schumacher
- Department of Psychiatry and Human BehaviorAlpert Medical School of Brown University/The Miriam Hospital, Weight Control and Diabetes Research CenterProvidenceRhode IslandUSA
| | - Rena Wing
- Department of Psychiatry and Human BehaviorAlpert Medical School of Brown University/The Miriam Hospital, Weight Control and Diabetes Research CenterProvidenceRhode IslandUSA
| | - J. Graham Thomas
- Department of Psychiatry and Human BehaviorAlpert Medical School of Brown University/The Miriam Hospital, Weight Control and Diabetes Research CenterProvidenceRhode IslandUSA
| | - Jelena Pavlovic
- Department of Neurology and the Montefiore Headache CenterAlbert Einstein College of Medicine/Montefiore Medical CenterBronxNew YorkUSA
| | - Kathleen Digre
- Department of NeurologyUniversity of Utah Health Sciences CenterSalt Lake CityUtahUSA
| | - Samantha Farris
- Department of Psychology, RutgersThe State University of New JerseyPiscatawayNew JerseyUSA
| | - Kristine Steffen
- Department of Pharmaceutical SciencesNorth Dakota State UniversityFargoNorth DakotaUSA
- Neuropsychiatric Research InstituteNorth Dakota State UniversityFargoNorth DakotaUSA
| | - David Sarwer
- Center for Obesity Research and Education, College of Public HealthTemple UniversityPhiladelphiaPennsylvaniaUSA
| | - Dale Bond
- Department of Psychiatry and Human BehaviorAlpert Medical School of Brown University/The Miriam Hospital, Weight Control and Diabetes Research CenterProvidenceRhode IslandUSA
| |
Collapse
|
8
|
Female Sexual Dysfunction as a Warning Sign of Chronic Disease Development. CURRENT SEXUAL HEALTH REPORTS 2019. [DOI: 10.1007/s11930-019-00229-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
|
9
|
Zhao S, Wang J, Liu Y, Luo L, Zhu Z, Li E, Zhao Z. Association Between Multiple Sclerosis and Risk of Female Sexual Dysfunction: A Systematic Review and Meta-Analysis. J Sex Med 2018; 15:1716-1727. [PMID: 30393105 DOI: 10.1016/j.jsxm.2018.09.016] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2018] [Revised: 09/14/2018] [Accepted: 09/26/2018] [Indexed: 12/31/2022]
Abstract
INTRODUCTION It has been reported that multiple sclerosis (MS) would increase the susceptibility to female sexual dysfunction (FSD). AIM To assess whether MS was a risk factor for FSD through a comprehensive literature review and meta-analysis. METHODS MEDLINE (PubMed), Embase, Cochrane Library, and PsychINFO databases were systematically searched for all studies reporting sexual function in women with MS. The protocol for this meta-analysis is available from PROSPERO (CRD42018094392). MAIN OUTCOME MEASURES The association between MS and risk of FSD was summarized using relative risk or standard mean differences with 95% CI. Subgroup and sensitivity analyses were conducted to detect potential bias. RESULTS Overall, 1,485 women participants (the mean age ranged from 29.15 to 45.89 years) were included from 9 studies (4 cross-sectional and 5 case-control studies); 826 of them were patients with MS, with a mean disease duration from 2.7 to 16.51 years. Synthesis of results revealed that MS was significantly associated with an increased risk of FSD (relative risk 1.87, 95% CI 1.25-2.78, P = .002; heterogeneity: I2 = 89.0%, P < .001). Women with MS had significantly lower values in total Female Sexual Function Index scores as compared with healthy controls (standard mean differences -2.41,95% CI -3.87 to -0.96, P = .017; heterogeneity: I2 = 97.2%, P = .001). The grading of recommendations assessment, development, and evaluation-relevant outcomes revealed that the absolute effect of MS on FSD was 434 more per 1000 (from 125 more to 888 more); and the overall quality of the evidence was judged as low. CLINICAL IMPLICATIONS The present meta-analysis indicates that women patients with MS have a significant elevated risk of sexual dysfunction, which should raise awareness of the potential association between MS and FSD by both neurologists and urologists. STRENGTHS & LIMITATIONS This the first study to summarize all available evidence for combining the odds on the association between MS and the risk of developing FSD. However, all the included studies were observational design, which may downgrade this evidence. CONCLUSION Results of this meta-analysis revealed a potential hazardous effect of MS for developing FSD. High-quality stringently controlled studies with large sample size are still warranted to validate this relationship. Zhao S, Wang J, Liu Y, et al. Association Between Multiple Sclerosis and Risk of Female Sexual Dysfunction: A Systematic Review and Meta-analysis. J Sex Med;15:1716-1727.
Collapse
Affiliation(s)
- Shankun Zhao
- Department of Urology and Andrology, Minimally Invasive Surgery Center, Guangdong Provincial Key Laboratory of Urology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
| | - Jiamin Wang
- Department of Urology and Andrology, Minimally Invasive Surgery Center, Guangdong Provincial Key Laboratory of Urology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
| | - Yangzhou Liu
- Department of Urology and Andrology, Minimally Invasive Surgery Center, Guangdong Provincial Key Laboratory of Urology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
| | - Lianmin Luo
- Department of Urology and Andrology, Minimally Invasive Surgery Center, Guangdong Provincial Key Laboratory of Urology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
| | - Zhiguo Zhu
- Department of Urology and Andrology, Minimally Invasive Surgery Center, Guangdong Provincial Key Laboratory of Urology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
| | - Ermao Li
- Department of Urology and Andrology, Minimally Invasive Surgery Center, Guangdong Provincial Key Laboratory of Urology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
| | - Zhigang Zhao
- Department of Urology and Andrology, Minimally Invasive Surgery Center, Guangdong Provincial Key Laboratory of Urology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
| |
Collapse
|
10
|
Kucukdurmaz F, Inanc Y, Inanc Y, Resim S. Sexual dysfunction and distress in premenopausal women with migraine: association with depression, anxiety and migraine-related disability. Int J Impot Res 2018; 30:265-271. [PMID: 30068979 DOI: 10.1038/s41443-018-0049-z] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2017] [Revised: 04/17/2018] [Accepted: 05/19/2018] [Indexed: 01/23/2023]
Abstract
Migraine is a chronic disorder associated with impaired quality of life as well as sexual function. However, data about the sexual distress in women with migraine were lacked.This study aimed to determine the incidence and associated risk factors of both sexual function and distress in premenopausal women with migraine. Sixty-nine women diagnosed with migraine were included. Sexual function and distress were assessed by Female sexual function index (FSFI) and Female sexual distress scale-revised (FSDS-R), respectively. Depression and anxiety were investigated by Hospital depression and anxiety scale (HADS). Migraine related disability was evaluated by Migraine disability assessment scale (MIDAS) and average severity of pain was determied by Visual analog scale (VAS). Fifty-five women reported to have sexual dysfunction. Any headache-related feature including MIDAS and VAS scores, depression or anxiety was found to be related with sexual dysfunction. Sexual distress was noted in 37 cases, and depression, VAS and MIDAS scores were significantly higher in women with sexual distress. This study showed that women with migraine should be screened both for sexual dysfunction and distress to help clinicians dealing with sexual medicine to improve the standart of patient care in their regular practice. Special attention should be given to the ones whose MIDAS and VAS scores were high and who had depression.
Collapse
Affiliation(s)
- Faruk Kucukdurmaz
- Department of Urology, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
| | - Yılmaz Inanc
- Department of Neurology, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey
| | - Yusuf Inanc
- Department of Neurology, Gaziantep University, Gaziantep, Turkey
| | - Sefa Resim
- Department of Urology, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey
| |
Collapse
|
11
|
Buse DC, Powers SW, Gelfand AA, VanderPluym JH, Fanning KM, Reed ML, Adams AM, Lipton RB. Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO Study. Headache 2018; 58:512-524. [DOI: 10.1111/head.13254] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/09/2017] [Indexed: 11/28/2022]
Affiliation(s)
- Dawn C. Buse
- Montefiore Medical Center; Bronx NY USA
- Department of Neurology; Albert Einstein College of Medicine; Bronx NY USA
| | - Scott W. Powers
- Headache Center and Division of Behavioral Medicine and Clinical Psychology; Cincinnati Children's Hospital; Cincinnati OH USA
- University of Cincinnati College of Medicine; Cincinnati OH USA
| | - Amy A. Gelfand
- UCSF Pediatric Headache Center and Division of Child Neurology; San Francisco CA USA
| | | | | | | | | | - Richard B. Lipton
- Montefiore Medical Center; Bronx NY USA
- Department of Neurology; Albert Einstein College of Medicine; Bronx NY USA
- Department of Epidemiology and Population Health; Albert Einstein College of Medicine; Bronx NY USA
| |
Collapse
|